Video

Dr. Spiess on the Rationale for Investigating the MTAP Pathway in Genitourinary Cancers

Philippe E. Spiess, MD, MS, FACS, discusses the rationale for investigating the MTAP pathway in genitourinary cancers.

Philippe E. Spiess, MD, MS, FACS, genitourinary oncologist, assistant chief, Surgical Services, Moffitt Cancer Center, full professor of Oncology, Urology, the University of South Florida, Morsani College of Medicine, discusses the rationale for investigating the MTAP pathway in genitourinary cancers.

Though there are several options for initial treatment in genitourinary cancers, including prostate cancer, bladder cancer, and kidney cancer, limited resources exist beyond those therapies if patients do not respond, Spiess says. To address these needs, researchers have come to understand some of the genetic and biological pathways in these cancers, including the MTAP pathway, which specifically plays a role in carcinogenesis, Spiess adds.

Research aimed to investigate difficult-to-treat subsets of cancers by better understanding the importance of MTAP deletions, Spiess continues. Learning how to target this pathway could help the development and use of certain types of novel therapies, Spiess concludes.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Addressing Unmet Needs in HER2+ Metastatic BTC
Video

Addressing Unmet Needs in HER2+ Metastatic BTC

Apr 24th 2025 - Apr 25th 2026

online-activity
Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2
Video

Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2

Apr 23rd 2025 - Apr 24th 2026

online-activity
(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments
Video

(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

Apr 23rd 2025 - Apr 24th 2026

online-activity